Autosomal recessive erythropoietic protoporphyria in the United Kingdom: prevalence and relationship to liver disease

6- 10 Most individuals who are heterozygous for these mutations are asymptomatic, despite having half-normal FECH activities. 11 For protoporphyrin to accumulate sufficiently to cause photosensitivity, reduction of FECH activity to below a critical threshold of about 35% of normal is required. 11- 1...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medical genetics Vol. 41; no. 8; p. e105
Main Authors: Whatley, S D, Mason, N G, Khan, M, Zamiri, M, Badminton, M N, Missaoui, W N, Dailey, T A, Dailey, H A, Douglas, W S, Wainwright, N J, Elder, G H
Format: Journal Article
Language:English
Published: England BMJ Publishing Group Ltd 01-08-2004
BMJ Publishing Group LTD
BMJ Group
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:6- 10 Most individuals who are heterozygous for these mutations are asymptomatic, despite having half-normal FECH activities. 11 For protoporphyrin to accumulate sufficiently to cause photosensitivity, reduction of FECH activity to below a critical threshold of about 35% of normal is required. 11- 14 In most patients, this additional reduction results from inheritance of a low expression FECH allele trans to a severe mutation. 10, 15- 18 The low expression allele is the C variant of a single nucleotide polymorphism (SNP; IVS3-48C/T) in intron 3 of the FECH gene. 18 Because the IVS3-48C allele is common in the general population, being present in about 11% of the white inhabitants of France, 18 inheritance trans to a severe FECH mutation occurs within EPP families at a frequency that is high enough to produce a pattern of inheritance of overt EPP resembling an autosomal dominant disease with incomplete penetrance. [...]autosomal recessive EPP appears to be clinically indistinguishable from EPP in which an FECH mutation on one allele is trans to a low expression IVS3-48C allele but may carry a much higher risk of severe liver disease.
Bibliography:istex:0E1BF951EE076FDEDF82D132818939492F1077FE
href:jmedgenet-41-e105.pdf
PMID:15286165
ark:/67375/NVC-88MM5M9B-7
local:041e105
Correspondence to:
 Professor G H Elder
 Department of Medical Biochemistry and Immunology, University of Wales College of Medicine, Cardiff CF14 4XN, UK; ghelder@trillium.fsworld.co.uk
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2593
1468-6244
1468-6244
DOI:10.1136/jmg.2003.016121